{"filings":[{"id":200406,"accession_number":"0001171843-24-006863","cik":806517,"company_name":"PSYCHEMEDICS CORP","ticker":"PMDI","form_type":"8-K","filed_at":"2024-12-10T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Psychemedics closes stock purchase with 3K LP; repurchases shares for fractional split coverage","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["3K Limited Partnership bought 1,409,712 shares at $2.35 on Dec 3, 2024.","Company repurchased 320,708 shares from 3K on Dec 10, 2024 at same $2.35 price.","Funds used to buy fractional shares from reverse stock split and provide $500K working capital.","Transaction closed with Peter Kamin entities, including trusts and a foundation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":14686752.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200405,"accession_number":"0001171843-24-006701","cik":806517,"company_name":"PSYCHEMEDICS CORP","ticker":"PMDI","form_type":"8-K","filed_at":"2024-12-03T23:59:59+00:00","items":["3.01","8.01","9.01"],"status":"ready","headline":"Psychemedics executes reverse/forward stock split, plans Nasdaq delisting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stock split effective Dec 3, 2024: 1-for-5,000 reverse split followed by 5,000-for-1 forward split.","Holders of fewer than 5,000 pre-split shares receive $2.35 per share in cash and are cashed out.","Stockholders with 5,000 or more shares see no net change in share count.","Company intends to voluntarily delist from Nasdaq and deregister, filing Form 25 and Form 15.","Expected annual cost savings exceeding $845,000 from delisting and deregistration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":14686752.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200404,"accession_number":"0001171843-24-006571","cik":806517,"company_name":"PSYCHEMEDICS CORP","ticker":"PMDI","form_type":"8-K","filed_at":"2024-11-25T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Psychemedics shareholders approve reverse-forward stock split and ratify stock purchase agreement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Re-elected five directors: Robyn C. Davis, Brian Hullinger, Peter H. Kamin, Darius G. Nevin, Andrew M. Reynolds with votes ranging 3.70–3.73M for.","Approved reverse stock split (ratio 1:4,000–6,000) and immediate forward split (4,000–6,000:1); Board sets exact ratio.","Ratified Stock Purchase Agreement dated Aug 12, 2024, with 2,981,855 for vs 1,091,026 against.","Non-binding advisory vote on executive compensation passed with 3,654,822 for; auditor Whitley Penn LLP ratified for FY 2024.","Reverse split vote: 3,002,727 for, 1,099,996 against; broker non-votes 1,104,904."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.15,"market_cap_usd":14686752.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200403,"accession_number":"0001171843-24-006285","cik":806517,"company_name":"PSYCHEMEDICS CORP","ticker":"PMDI","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Psychemedics Q3 revenue falls 9% to $5.2M; net loss narrows to $0.5M from $2.1M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2024 revenue $5.2M, down 9% YoY from $5.7M; nine-month revenue $15.3M, down 11%.","Net loss narrowed to $0.5M ($0.09/share) vs $2.1M ($0.36/share) in prior-year Q3.","Nine-month net loss $2.1M ($0.35/share) vs $3.2M ($0.56/share) in 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":15260000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":14686752.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216433,"accession_number":"0001171843-24-004747","cik":806517,"company_name":"PSYCHEMEDICS CORP","ticker":"PMDI","form_type":"8-K","filed_at":"2024-08-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Psychemedics Q2 revenue down 15% to $4.7M; net loss widens to $0.14/sh","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2024 revenue $4.7M vs $5.5M YoY (-15%); net loss $0.8M ($0.14/sh) vs $0.7M ($0.13/sh).","H1 2024 revenue $10.1M vs $11.4M YoY (-12%); net loss $1.5M ($0.26/sh) vs $1.1M ($0.19/sh).","CEO cites continued lower client hiring as primary driver of revenue decline.","Company adjusting operating costs while seeking new markets and applications."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":10085000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":14686752.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216432,"accession_number":"0001171843-24-004695","cik":806517,"company_name":"PSYCHEMEDICS CORP","ticker":"PMDI","form_type":"8-K","filed_at":"2024-08-12T23:59:59+00:00","items":["1.01","3.02","8.01","9.01"],"status":"ready","headline":"Psychemedics board approves going-private transaction via reverse stock split, cash-out at $2.35/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split at ratio between 1:4,000 and 1:6,000; shares below ratio denominator cashed out at $2.35 each.","Estimated 1.2M shares (21% of outstanding) cashed out, aggregate cost ~$2.8M plus ~$700k expenses.","Company expects annual savings exceeding $900k after terminating SEC reporting and Nasdaq listing.","Stock purchase agreement with 3K/Kamin entities for up to $3.75M at $2.35/share to fund cash-out and working capital.","Transaction subject to stockholder approval at 2024 annual meeting expected in fall 2024; board may abandon."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":14686752.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236013,"accession_number":"0001171843-24-003414","cik":806517,"company_name":"PSYCHEMEDICS CORP","ticker":"PMDI","form_type":"8-K","filed_at":"2024-06-12T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Psychemedics dismisses BDO USA as auditor, engages Whitley Penn LLP","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed BDO USA as independent auditor on June 6, 2024; engaged Whitley Penn LLP on June 12, 2024.","No disagreements or reportable events with BDO in the two most recent fiscal years and interim period.","BDO's audit reports for fiscal years ended Dec 31, 2023 and 2022 were unqualified.","Company provided BDO with a copy of the statements and received BDO's letter to SEC agreeing with the statements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":14686752.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236012,"accession_number":"0001171843-24-003243","cik":806517,"company_name":"PSYCHEMEDICS CORP","ticker":"PMDI","form_type":"8-K","filed_at":"2024-06-03T23:59:59+00:00","items":["1.02"],"status":"ready","headline":"Psychemedics terminates Culver City lease; expects $250K net savings","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Lease termination effective June 30, 2024 for 5750 Hannum Ave, Culver City, CA.","Consideration payable to landlord is approximately $110,000.","Company expects $250,000 net cost savings over remaining lease term.","Original lease dated July 29, 2019 with Culver City/Hannum, LLC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":14686752.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236011,"accession_number":"0001171843-24-002873","cik":806517,"company_name":"PSYCHEMEDICS CORP","ticker":"PMDI","form_type":"8-K","filed_at":"2024-05-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Psychemedics reports Q1 2024 revenue down 9% to $5.4M; net loss widens to $0.7M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $5.4M vs $5.9M in Q1 2023, a 9% decline.","Net loss $0.7M ($0.12 per share) vs loss of $0.4M ($0.07) in prior year.","CEO cites revenue decrease but remains optimistic; focusing on client acquisition and new market applications."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":5357000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":14686752.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":253758,"accession_number":"0001171843-24-001669","cik":806517,"company_name":"PSYCHEMEDICS CORP","ticker":"PMDI","form_type":"8-K","filed_at":"2024-03-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Psychemedics reports 2023 revenue down 12% to $22.1M, net loss widens to $4.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $22.1M in 2023, down 12% from $25.2M in 2022.","Net loss widened to $4.2M ($0.72 per share) from $1.1M loss ($0.19) in 2022.","Cash & equivalents fell to $2.0M from $4.8M at end of 2022.","Operating expenses increased to $11.3M from $10.4M, with G&A rising to $7.2M.","CEO cites ongoing labor shortage; plans cost reductions and pursuit of new markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":14686752.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}